GoodRx (GDRX) Earnings Date, Estimates & Call Transcripts

$8.85

+0.11 (+1.26%)

(As of 07/26/2024 ET)

Upcoming Earnings Date: Aug. 8
Before Market Opens
Confirmed
Actual EPS (May. 9): $0.03 Missed By -$0.01
Consensus EPS (May. 9): $0.04

GDRX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

GDRX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad DTI

How a $0.25 cent option contract makes my top traders feel

If you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time! While I kept the finer details of these $0.25 Cent Trades under wraps until recently…

Click now to see for yourself what $0.25 Cent Trades is all about

GoodRx Analyst EPS Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate	Company Guidance
Q1 2024	1	$0.04	$0.04	$0.04
Q2 2024	1	$0.03	$0.03	$0.03
Q3 2024	1	$0.03	$0.03	$0.03
Q4 2024	1	$0.02	$0.02	$0.02
FY 2024	4	$0.12	$0.12		$0.12

GDRX Earnings Date and Information

GoodRx last announced its earnings data on May 9th, 2024. The reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.04 by $0.01. The company earned $197.88 million during the quarter, compared to analysts' expectations of $196.20 million. GoodRx has generated ($0.01) earnings per share over the last year (($0.01) diluted earnings per share). Earnings for GoodRx are expected to grow by 47.06% in the coming year, from $0.17 to $0.25 per share. GoodRx has confirmed that its next quarterly earnings report will be published on Thursday, August 8th, 2024. GoodRx will be holding an earnings conference call on Thursday, August 8th at 8:00 AM Eastern. Interested parties can register for or listen to the call..

GoodRx Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
8/8/2024 (Confirmed)	-	-	-	-	-	-	-
5/9/2024	Q1 2024	$0.04	$0.03	($0.01)	$0.06	$196.20 million	$197.88 million
2/29/2024	Q4 2023	$0.02	$0.02	-	$0.10	$195.59 million	$196.64 million
11/9/2023	Q3 2023	$0.06	$0.06	-	$0.09	$188.52 million	$180.00 million
8/9/2023	Q2 2023	$0.01	$0.02	+$0.01	($0.10)	$186.90 million	$189.68 million
5/10/2023	Q1 2023	$0.01	$0.01	-	$0.03	$181.87 million	$183.99 million
2/28/2023	Q4 2022	($0.01)	$0.01	+$0.02	$0.02	$178.17 million	$184.11 million
Get the Latest News and Ratings for GDRX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for GoodRx and its competitors with MarketBeat's FREE daily newsletter.
8/8/2022	Q2 2022	($0.02)	$0.02	+$0.04	$0.04	$184.71 million	$191.80 million
5/9/2022	Q1 2022	$0.02	$0.03	+$0.01	$0.03	$200.61 million	$203.30 million
2/28/2022	Q4 2021	$0.03	$0.01	($0.02)	$0.12	$217.51 million	$213.30 million
11/10/2021	Q3 2021	$0.01	$0.09	+$0.08	$0.02	$196.08 million	$195.10 million
8/12/2021	Q2 2021	$0.01	$0.08	+$0.07	($0.07)	$174.15 million	$176.64 million
5/13/2021	Q1 2021	$0.07	$0.07	-	($0.02)	$160.61 million	$160.40 million
3/11/2021	Q4 2020	$0.06	$0.08	+$0.02	($0.46)	$148.01 million	$153.50 million
11/12/2020	Q3 2020	($0.03)	$0.09	+$0.12	($0.29)	$135.05 million	$140.40 million

GoodRx Earnings - Frequently Asked Questions

When is GoodRx's earnings date?: GoodRx has confirmed that its next quarterly earnings data will be published on Thursday, August 8th, 2024. Learn more on GDRX's earnings history.
What guidance has GoodRx issued on next quarter's earnings?: GoodRx updated its FY 2024 earnings guidance on Thursday, May, 9th. The company issued revenue guidance of $800.0 million-$810.0 million, compared to the consensus revenue estimate of $801.0 million.
Did GoodRx beat their earnings estimates last quarter?: In the previous quarter, GoodRx (NASDAQ:GDRX) missed the analysts' consensus estimate of $0.04 by $0.01 with a reported earnings per share (EPS) of $0.03. Learn more on analysts' earnings estimate vs. GDRX's actual earnings.
How much revenue does GoodRx generate each year?: GoodRx (NASDAQ:GDRX) has a recorded annual revenue of $764.16 million.
How much profit does GoodRx generate each year?: GoodRx (NASDAQ:GDRX) has a recorded net income of -$8.87 million. GDRX has generated -$0.01 earnings per share over the last four quarters.
What is GoodRx's price-to-earnings ratio?: GoodRx (NASDAQ:GDRX) has a forward price-to-earnings ratio of 52.06. The price/earnings-to-growth ratio is 4.18.
What is GoodRx's EPS forecast for next year?: GoodRx's earnings are expected to grow from $0.17 per share to $0.25 per share in the next year, which is a 47.06% increase.